Experimental and Computational Data on Indazole-Pyridine Derivatives: Synthesis, Characterization, and Anticancer Evaluation
1★, 2★ Corresponding author
- 1Faculty of Pharmacy, Parul University, Limda, Waghodia, Vadodara, Gujarat, INDIA.
- 2Department of Pharmaceutical Chemistry, Parul College of Pharmacy and Research, Faculty of Pharmacy, Parul University, Bopal, Ahmedabad, Gujarat, INDIA.
CORRESPONDENCE
Kinjal Parmar
Faculty of Pharmacy, Parul University, Limda, Waghodia, Vadodara, Gujarat, INDIA.
Received: 14-05-2026; Revised: 08-06-2026; Accepted: 24-07-2026.
Volume 15, Issue 2 · pp. 559–566 · 2026 · DOI: 10.5530/ajbls.20260139
ABSTRACT
Introduction: Breast cancer remains a major cause of cancer-related mortality among women worldwide, highlighting the need for novel therapeutic agents. Materials and Methods: Two indazole-pyridine derivatives (7i and 7j) were synthesized and characterized using FTIR, ¹H-NMR, ¹³C-NMR, and mass spectrometry. Molecular docking was performed to evaluate binding interactions. In vitro cytotoxicity against the MCF-7 cell line was assessed using the SRB assay (10-80 µg/mL). Results: Docking studies indicated stable ligand-receptor interactions. Both compounds exhibited dose-dependent cytotoxicity. Compound 7j showed strong antiproliferative activity (GI₅₀<10 µg/mL), while compound 7i showed moderate activity (GI₅₀=33.6 µg/mL). Conclusion: The presence of a pyrrolidine moiety in 7j enhances activity. These derivatives represent promising scaffolds for further optimization as anticancer agents.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Parmar, K., & Panchal, I. (2026). Experimental and Computational Data on Indazole-Pyridine Derivatives: Synthesis, Characterization, and Anticancer Evaluation. Asian Journal of Biological and Life sciences, 15(2), 559–566. https://doi.org/10.5530/ajbls.20260139
